New

Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →

Help us improve your experience. Please confirm your investor type:

Compare ETFs Easily

The Ultimate ETF Comparison Tool - Try Now!

Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.

ETF screener

WDNA ETF · WisdomTree BioRevolution UCITS ETF

The WDNA Exchange Traded Fund (ETF) is provided by WisdomTree. It is built to track an index: WisdomTree BioRevolution ESG Screened Index. The WDNA ETF provides physical exposure, so by buying it you actually own parts of all the 82 underlying holdings. The dividend policy is capitalization.
Last update Yesterday at 7:00 AM UTC
LIVE
CLOSED
This fund is part ofDeveloped Market Blended Cap1M perf.+6.55%
Last price
$19.51
1M perf.
-3.74%
1M flows
+€1.2M
AuM
€12M
TER
0.45%
Rating
ESG Consensus®
esg grade icon
WDNA
$19.51

Performance & flows

Segment for quartile rank
February 16, 2026 → May 14, 2026
0-8-6-4-202468%MARAPRMAYMARAPRMAY
Create a free account to view the flows graph
WDNA
$20.04
+0.65%
Developed Market Blended Cap
+6.57%

Historic performance and flows

1M3M1Y3Y5YMTDQTDYTD
Perf.
-3.74%
icon
+0.65%
icon
+54.93%
icon
+5.52%
icon
N/A
-0.39%
+1.80%
+5.17%
icon
Flows

Key fund info

Segment for quartile rank
Main characteristics
ISIN
IE000O8KMPM1
AuM
€12M
icon
TER
0.45%
icon
Replication rating
icon
ESG Consensus®
esg grade icon
icon
More details
NAV
5/14/2026
$20.04
1D NAV change
-1.06%
Dividend policy
Replication method
Direct (Physical)
Replication model
Optimized sampling
No. of holdings
82
Inception date
12/3/2021
Jurisdiction
Ireland
Distribution
Austria
Switzerland
Sweden
Spain
Norway
Legal structure
Irish Collective Asset-management Vehicle
Base currency
USD
Classification
Product type
Asset class
Factors
N/A
Investment strategy
The WisdomTree BioRevolution UCITS ETF (the “Fund”) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution ESG Screened Index (the "Index").
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
half moonhalf moon double
New to Trackinsight?
For individual investors

Trackinsight
Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.
More fund data
Compare up to 3 funds
More screener filters
Choose your own screener columns from 100+ metrics
Lists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring
For professional investors

Trackinsight
Enterprise

Trackinsight Enterprise addresses the everyday operational, regulatory, and analytical pain points faced by professional and institutional ETF investors, from selection to execution.
Request a free trial
More professional services:ETF Data ServicesDue Diligence Services

Similar ETFs

WDNA
1M perf.
-3.76%
TER
0.45%
GNOG
1M perf.
-1.74%
TER
0.5%
GNOM
1M perf.
-1.72%
TER
0.5%
HTEC
1M perf.
+0.18%
TER
0.8%
DOCG
1M perf.
-2.25%
TER
0.49%

Advertisement

Risk profile

Segment for quartile rank

Historical risk/return profile

3M1Y3Y5Y
Returns
+0.65%
icon
+54.93%
icon
+5.52%
icon
N/A
Volatility
Perf./Volatility
Max drawdown
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
1
2
3
4
5
6
7
PRIIPS
1
2
3
4
5
6
7
More exposure metrics are available, exclusively in Trackinsight Enterprise

Exposure

Countries
USA
81.54%
Switzerland
5.15%
Denmark
3.43%
Germany
2.08%
Bermuda
1.52%
Japan
1.15%
United Kingdom
1.07%
Unavailable
2.65%
Other
1.41%
Sectors
Health Care
80.51%
Materials
3.82%
Consumer Staples
2.19%
Energy
1.79%
Unavailable
11.68%
Diversification
Total weight of top 15 holdings out of 82
Top 15 holdings
Data as of March 31, 2026
MODERNA INC
JOHNSON&JOHNSON
UTD THERAPEUT
PFIZER
STOKE THERAPEUTICS INC
LILLY
AMGEN-T
NATERA
Create a free account to view top holdings
TWIST BIOSCIENCE CORP
AMICUS THERAPEUTICS
US86366E1064
BIONTECH SE ADR
IONIS PHARMACEUTICALS INC
ARCELLX
NOVOZYMES
Create a free account to view top holdings
More risk metrics are available, exclusively in Trackinsight Enterprise

Sustainability

Integrates ESG criteria
Yes
SDG

ESG Consensus® by Conser

Data as of February 27, 2026
Methodology

Our partner Conser gathers the industry's consensus on the business practices of the underlying holdings. We have computed the following metrics about WDNA ETF's sustainability, based on their methodology.

Learn more about Conser

ESG Consensus®
esg grade icon

ESG Consensus® is based on the Final Sustainability Grade, which itself consists of 10 grades. Our partner Conser calculates the exact grade, based on market intelligence, using their proprietary ESG Consensus® methodology.


WDNA’s has a Final Sustainability Grade of either A+, A, or A-.

This fund’s exact Final Sustainability Grade is available in Trackinsight Enterprise.
Learn more about Trackinsight Enterprise
Holdings review
91.15% of holdings have positive scoring
11.59% of holdings have negative scoring
14.27%
57.16%
19.71%
7.48%
Consensus levels
Strong
Medium
Weak
More sustainability metrics are available, exclusively in Trackinsight Enterprise

Replication

Trackinsight replication rating:
1-year trailing difference
As of April 30, 2026
Create a free account to view the replication graph
WDNA
N/A
Replication quality
Calculated over 12m, as of April 30, 2026
Tracking error
Tracking difference
1-year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Replication information
Index
Index ticker
Index dividend policy
Replication method
Replication model

Issuer

WisdomTree
WisdomTree ID Card
Number of funds
436
Total AuM
€139.4B
Expense ratio range
0.05% - 4.32%
Average expense ratio
0.5421%

Frequently asked questions about WDNA

What does WisdomTree BioRevolution UCITS ETF, WDNA, invest in?

WDNA is a Passive ETF. This ETF provides exposure to Equally Weighted Developed markets Equities.

Which benchmark or index does WDNA replicate?

WDNA tracks the WisdomTree BioRevolution ESG Screened Net Return Index - USD, through a optimized sampling replication method.

What is the Total Expense ratio (TER) of WDNA?

WDNA carries a total expense ratio (TER) of 0.45%, indicating the annual cost for holding the fund.

When was WDNA launched?

WDNA was introduced to the market on December 3, 2021. It trades on Austria, among other exchanges

Who is the ETF issuer of WDNA?

WisdomTree BioRevolution UCITS ETF, WDNA, is provided by WisdomTree. Learn more about WisdomTree here.

What is the current assets under management (AUM) of WDNA?

WDNA oversees €12M in assets as of May 14, 2026.

How has WDNA performed lately?

Based on data from May 14, 2026, WDNA returned -3.74% over the past month, 0.65% over the last three months and 5.17% year-to-date.

What are the latest inflows or outflows for WDNA?

As of May 14, 2026, WDNA recorded net flows of +€1.2M over the last month and +€3.8M year-to-date.

Does WDNA distribute dividends?

WDNA follows a capitalizing, meaning it reinvests income within the fund.

What are the main country or region exposures of WDNA?

As of March 31, 2026, WDNA has significant geographic allocations in USA, Switzerland and Denmark.

In which sector or theme does WDNA invest in?

As of March 31, 2026, WDNA focuses largely on Health Care, Materials and Consumer Staples.

How many securities does WDNA hold and how diversified is it?

As of March 31, 2026, WDNA holds 82 positions in its portfolio, with 38.45% of assets concentrated in its top 15 holdings.

What are the main positions in WDNA?

As of March 31, 2026, WDNA top three holdings include MODERNA INC, JOHNSON&JOHNSON and UTD THERAPEUT.

What is the base currency of WDNA?

The base currency of WDNA is USD.

Advertisement

Trackinsight

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy  |  Cookie policy  |    |  Terms of use  |  Imprint
Trackinsight